Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06094816

Forebrain Electroneutral Transporters in Salt-sensitive Hypertension: an MRI Study

The overall objective of this project is to identify the key salt-sensing regions of the brain and determine the underlying mechanism of sodium sensing. The investigators will assess how the brain responds to an acute increase of salt in the blood using MRI. This will be done during a 30-minute infusion of a saline solution containing 3% salt. One trial will be conducted with a salt sensing channel blocker and one trial without the salt sensing channel blocker. This will help to assess the role of a specific salt sensing channel in the brain. Salt sensitivity of BP will be assessed using 7-day dietary feeding where participants will be given food to consume for 7-days. Comparisons will be made between salt resistant (no change in blood pressure going from low to high salt diets) and salt sensitive adults (a change in blood pressure going from low to high salt diets). The investigators think the changes in MRI will be greater in salt sensitive compared to salt resistant subjects.

Recruiting

Interested in participating?

Request Info

Key information

Age range

40 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

University of Delaware

Newark, Delaware, 19713, United States

Location status: Recruiting

Location contact

Ginny Nuckols, PhD

CONTACT

[email protected]

Katherine Masso, BS

CONTACT

[email protected]

About this study

The ability of the brain to sense changing sodium levels in the blood is critical in mediating the neurohumoral responses to hypernatremia, however, the mechanisms underlying sodium sensing in humans is poorly understood. The purpose of this study is to identify key sodium-sensing regions of the human brain in middle-aged men and women with high blood pressure and determine if the Na-K-2Cl co-transporter (NKCC2) mediates the neurohumoral response to acute hypernatremia. The investigators plan on comparing these central sodium responses to acute hypernatremia between salt-sensitive and salt-resistant adults. In this randomized double-blinded crossover study subjects will have a 3% NaCl (hypertonic saline) infusion with or without NKCC2 antagonism (furosemide). Completion of this project will increase the understanding of blood pressure regulation, which has major public health implications.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: > 40 years or < 60 years
  • Blood pressure: > 100/60 mmHg or < 140/90 mmHg
  • BMI: > 18.5 kg/m2 or < 35 kg/m2
  • Serum potassium: > 3.5 mmol/L or < 5.5 mmol/L
  • No history of cardiovascular, renal, metabolic, or neurological disease

Exclusion criteria

  • Age: < 40 years or > 60 years
  • Blood pressure: < 100/60 mmHg or > 140/90 mmHg
  • BMI: < 18.5 kg/m2 or > 30 kg/m2
  • Serum potassium: < 3.5 mmol/L or > 5.5 mmol/L
  • Abnormal ECG
  • History of - cardiovascular, cancer, metabolic, respiratory, renal disease
  • Hormone replacement therapy
  • Current tobacco or nicotine use
  • Pregnant or nursing mothers
  • Major brain injury (concussions do not count)
  • Clinically diagnosed psychiatric or neurological disorder
  • Clinically diagnosed anxiety or depression
  • Psychiatric, neurological, anxiety or depression medications
  • Hypertension medications
  • Sulfonamide drug allergy
  • Contra-indications to MRI (implants, metal, etc)
  • Claustrophobia

Treatment and study plan

Furosemide (Diuretic)

Drug

The diuretic furosemide will be given during a 3% hypertonic saline infusion to examine blockade of the NKCC2.

Other names: Lasix

Hypertonic Saline Infusion

Other

3% Hypertonic saline infusion to acutely increase sodium and osmolality

Primary outcomes

  1. Bold fMRI

    Time frame: 1 hour

    Intensity of sodium sensing regions of the brain

Secondary outcomes

  1. Blood Pressure

    Time frame: 1 hour

    Systolic and Diastolic Blood pressure responses to hypertonic saline

Other outcomes

  1. Sympathetic Nerve Activity

    Time frame: 1 hour

    sympathetic bursts per minute

Study contacts

Contact information is provided by the study sponsor or research team.

Megan Wenner, PhD

CONTACT

[email protected]

3028317343

Virginia Nuckols, PhD

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

University of Delaware

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

Registry information

Important dates

Study start
2024
Primary completion
2028
Study completion
2028
First posted
Oct 23, 2023
Registry last updated
Mar 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.